The Integrative Functional Regenerative Medicine Approach
A comprehensive three-tiered therapeutic strategy designed to address facial skin quality through cellular, physical, and metabolic interventions.
Core Therapeutic Modalities
Our approach is built upon the principle that optimal facial skin rejuvenation requires multimodal intervention. Umbilical cord mesenchymal stem cells serve as the foundational biological component, while physical therapy and nutritional medicine provide the essential supportive framework.
Cellular Dermal Modulation Core
Umbilical cord-derived mesenchymal stem cells are utilized for their paracrine and immunomodulatory properties. These cells, along with their derivatives (exosomes), are administered through minimally invasive techniques to engage with dermal fibroblasts and support extracellular matrix remodeling.
Physical Medicine Integration
Customized supportive plans focus on facial tissue mobilization, lymphatic drainage, and microcirculation enhancement. Physical medicine techniques support the skin's regenerative capacity and complement the cellular therapy.
Nutritional Support
Nutritional medicine strategies are employed to reduce systemic inflammation, provide substrates for collagen synthesis, and support skin barrier function. IV fluid therapies with multivitamins integrate to support overall treatment response.
Clinical procedure visualization
Core Therapeutic Benefits
Umbilical cord mesenchymal stem cells and their derivatives offer multiple mechanisms of action in the adjunctive management of facial skin aging.
Dermal Inflammation Modulation
Reduction of chronic low‑grade dermal inflammation through broad immunomodulatory mechanisms targeting IL-6, TNF-α, and other pro‑inflammatory cytokines.
Extracellular Matrix Remodeling
Supports collagen type I and III synthesis, elastin production, and hyaluronic acid turnover, improving skin firmness and elasticity.
Immunoprivileged & Proliferative
UC-MSCs exhibit immunoprivileged characteristics, reducing alloreactivity while supporting local dermal homeostasis.
Mechanistic references: MSC paracrine signaling in dermal remodeling (PubMed) | Systematic review: MSCs for skin rejuvenation (PMC) | Clinical insights (ClinicalTrials.gov)
Key Mechanisms of UC-MSC & Derivatives in Facial Skin Rejuvenation
Your Adjunctive Regenerative Journey: A Practical Guide
Download our comprehensive walkthrough detailing the overall experience: from local travel logistics, lodging, and transportation services to payment methods. The guide also includes technical information on umbilical stem cells and derivatives (exosomes), supportive multivitamin IV fluid therapies, and essential pre- & post-treatment recommendations.
This resource provides objective information about supportive approaches and helps you plan your visit with clarity.
Download the Guide
No email required. Instant download.
Ideal Candidate Profile
The integrative regenerative medicine approach is designed for individuals seeking facial skin rejuvenation who have realistic expectations and are committed to participating in supportive nutritional and physical therapies. Appropriate candidates typically present with visible signs of skin aging, including fine lines, loss of elasticity, uneven tone, or dull complexion.
Ideal candidates are generally those without active skin infections or uncontrolled systemic diseases, who maintain realistic expectations and are committed to the comprehensive supportive plan.
- Visible signs of facial skin aging (fine lines, reduced elasticity)
- Desire for non-surgical, minimally invasive supportive approach
- Absence of active cutaneous infections or inflammatory dermatoses
- Realistic expectations regarding outcomes and timeline
- Commitment to participate in supportive physical and nutritional therapies
- Absence of contraindications to regenerative procedures
Candidate Evaluation
Comprehensive medical assessment to determine appropriateness for adjunctive regenerative intervention.
Important clinical note: This adjunctive approach is not a replacement for conventional dermatologic or aesthetic treatments. Patients should continue those treatments under the direction of their prescribing physician.
MSC adjunctive therapy for facial skin rejuvenation is not approved by the U.S. FDA, Mexican COFEPRIS (for this indication), or any other regulatory agency. It is considered an adjunctive, supportive procedure. Costs are discussed only after a consultation.
Professional Clinical Perspective
As medical professionals specializing in regenerative medicine, we approach facial skin rejuvenation with a commitment to evidence-based practice and patient-centered care. Our integrative functional approach recognizes that optimal outcomes often require addressing multiple contributing factors simultaneously.
We emphasize transparent communication regarding the current scientific understanding of regenerative techniques, the importance of supportive therapies, and the need for realistic expectations. Each treatment plan is individualized based on comprehensive evaluation, patient history, and specific clinical factors.
Our practice maintains a focus on safety, procedural precision, and thorough follow-up care to monitor progress and adjust supportive therapies as needed throughout the regenerative process.
— Nexus Regenerative Medicine Clinical Team